timtamtom personal page - To The Moon

timtamtom

No personal profile

18Follow

2Followers

2Topic

0Badge

07-10

Just don't be the bag holder

Nvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last

2021-09-21

Up up up and away

U.S. stocks gain at Tuesday's open

2021-06-29

Nice sharing

Sorry, the original content has been removed

2021-06-29

Whoa

NIO Stock Is Going Nuts. This Is the Best Explanation.

2021-06-18

Oh no

Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries

2021-06-18

Gr qt

Next Market Crash: 2 Top Growth Stocks to Buy Right Now

2021-06-18

$Palantir Technologies Inc.(PLTR)$Long term potential

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578209189176690","uuid":"3578209189176690","gmtCreate":1615115165327,"gmtModify":1615115165327,"name":"timtamtom","pinyin":"timtamtom","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":18,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":6,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.04","exceedPercentage":"80.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.27","exceedPercentage":"93.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":325739936772264,"gmtCreate":1720550519586,"gmtModify":1720550524097,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Just don't be the bag holder&nbsp;","listText":"Just don't be the bag holder&nbsp;","text":"Just don't be the bag holder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325739936772264","repostId":"2449477578","repostType":4,"repost":{"id":"2449477578","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1720491278,"share":"https://ttm.financial/m/news/2449477578?lang=&edition=fundamental","pubTime":"2024-07-09 10:14","market":"us","language":"en","title":"Nvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2449477578","media":"Dow Jones","summary":"Companies are spending big to develop their own AI chips so they don't have to keep paying Nvidia. Within a few years, AI chips will sell at a small fraction of Nvidia's 'only game in town' price.Artificial intelligence and seven  stocks have been driving the U.S. market's performance for a while. I agree with the market - these companies are magnificent. I'd want my kids to work for any of them.But there's a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia  when its shares were much lower. I'll always look dumb questioning apostasy until I'm not. I'm used to it.Then the conversation  shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microproce","content":"<html><head></head><body><p>Companies are spending big to develop their own AI chips so they don&#39;t have to keep paying Nvidia</p><p>Within a few years, AI chips will sell at a small fraction of Nvidia&#39;s &#39;only game in town&#39; price.</p><p>Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market&#39;s performance for a while. I agree with the market - these companies are magnificent. I&#39;d want my kids to work for any of them.</p><p>But there&#39;s a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a> when its shares were much lower. I&#39;ll always look dumb questioning apostasy until I&#39;m not. I&#39;m used to it.</p><p>I&#39;m fairly certain what I&#39;m about to say will age well, though not in a linear way. Let me tell you a story.</p><p>I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.</p><p>Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.</p><p>I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.</p><p>A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here&#39;s all you need to know: The laws of economics work the same way with microchips.</p><p>Today, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>, Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, <a href=\"https://laohu8.com/S/META\">Meta Platforms</a>, Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia&#39;s skyrocketing profitability is at their expense. Actually, it&#39;s a capital expenditure - only a portion of their spending that shows up in Nvidia&#39;s revenue shows up in Alphabet&#39;s earnings (income statement expenses), for example.</p><p>As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p><p>Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet&#39;s income statement in the form of depreciation, while the full $40,000 shows up in Nvidia&#39;s revenues. That&#39;s why these companies&#39; free cash flow often is much lower than their income.</p><p>These tech giants aren&#39;t pleased to be paying Nvidia for their needs. So, in addition to Intel <a href=\"https://laohu8.com/S/INTC\">$(INTC)$</a> and AMD <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a>, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven&#39;t heard of are working on AI chips.</p><p>Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia&#39;s &#34;only game in town&#34; price. The cure for high prices is high prices. This is what I love about capitalism.</p><p>The argument I hear about Nvidia stock is that it&#39;s not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it&#39;s a high valuation for a $3 trillion company, it&#39;s not &#34;insane.&#34;</p><p>But, and this is a huge but, the &#34;E&#34; in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-07-09 10:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Companies are spending big to develop their own AI chips so they don&#39;t have to keep paying Nvidia</p><p>Within a few years, AI chips will sell at a small fraction of Nvidia&#39;s &#39;only game in town&#39; price.</p><p>Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market&#39;s performance for a while. I agree with the market - these companies are magnificent. I&#39;d want my kids to work for any of them.</p><p>But there&#39;s a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a> when its shares were much lower. I&#39;ll always look dumb questioning apostasy until I&#39;m not. I&#39;m used to it.</p><p>I&#39;m fairly certain what I&#39;m about to say will age well, though not in a linear way. Let me tell you a story.</p><p>I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.</p><p>Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.</p><p>I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.</p><p>A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here&#39;s all you need to know: The laws of economics work the same way with microchips.</p><p>Today, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>, Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, <a href=\"https://laohu8.com/S/META\">Meta Platforms</a>, Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia&#39;s skyrocketing profitability is at their expense. Actually, it&#39;s a capital expenditure - only a portion of their spending that shows up in Nvidia&#39;s revenue shows up in Alphabet&#39;s earnings (income statement expenses), for example.</p><p>As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p><p>Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet&#39;s income statement in the form of depreciation, while the full $40,000 shows up in Nvidia&#39;s revenues. That&#39;s why these companies&#39; free cash flow often is much lower than their income.</p><p>These tech giants aren&#39;t pleased to be paying Nvidia for their needs. So, in addition to Intel <a href=\"https://laohu8.com/S/INTC\">$(INTC)$</a> and AMD <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a>, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven&#39;t heard of are working on AI chips.</p><p>Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia&#39;s &#34;only game in town&#34; price. The cure for high prices is high prices. This is what I love about capitalism.</p><p>The argument I hear about Nvidia stock is that it&#39;s not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it&#39;s a high valuation for a $3 trillion company, it&#39;s not &#34;insane.&#34;</p><p>But, and this is a huge but, the &#34;E&#34; in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU2458330243.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A-H1\" (SGDHDG) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","NVDA":"英伟达","LU0056508442.USD":"贝莱德世界科技基金A2","BK4512":"苹果概念","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","BK4511":"特斯拉概念","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0109392836.USD":"富兰克林科技股A","BK4514":"搜索引擎","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","BK4554":"元宇宙及AR概念","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4515":"5G概念","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","BK4553":"喜马拉雅资本持仓","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","IE00BD6J9T35.USD":"NEUBERGER BERMAN NEXT GENERATION MOBILITY \"A\" (USD) ACC","LU0276348264.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN\"AUP\" (USD) INC","LU0444971666.USD":"天利全球科技基金","BK4567":"ESG概念","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","BK4555":"新能源车","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","BK4566":"资本集团","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0289941410.SGD":"AB FCP I Dynamic Diversified AX SGD","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4559":"巴菲特持仓","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","BK4550":"红杉资本持仓"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2449477578","content_text":"Companies are spending big to develop their own AI chips so they don't have to keep paying NvidiaWithin a few years, AI chips will sell at a small fraction of Nvidia's 'only game in town' price.Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market's performance for a while. I agree with the market - these companies are magnificent. I'd want my kids to work for any of them.But there's a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia $(NVDA)$ when its shares were much lower. I'll always look dumb questioning apostasy until I'm not. I'm used to it.I'm fairly certain what I'm about to say will age well, though not in a linear way. Let me tell you a story.I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here's all you need to know: The laws of economics work the same way with microchips.Today, Alphabet $(GOOGL)$, Apple $(AAPL)$, Meta Platforms, Tesla $(TSLA)$ and Amazon $(AMZN)$, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia's skyrocketing profitability is at their expense. Actually, it's a capital expenditure - only a portion of their spending that shows up in Nvidia's revenue shows up in Alphabet's earnings (income statement expenses), for example.As competing products hit the market, Nvidia's sales will falter, and so will its margins and earnings.Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet's income statement in the form of depreciation, while the full $40,000 shows up in Nvidia's revenues. That's why these companies' free cash flow often is much lower than their income.These tech giants aren't pleased to be paying Nvidia for their needs. So, in addition to Intel $(INTC)$ and AMD $(AMD)$, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven't heard of are working on AI chips.Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia's \"only game in town\" price. The cure for high prices is high prices. This is what I love about capitalism.The argument I hear about Nvidia stock is that it's not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it's a high valuation for a $3 trillion company, it's not \"insane.\"But, and this is a huge but, the \"E\" in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia's sales will falter, and so will its margins and earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869930250,"gmtCreate":1632233667670,"gmtModify":1676530730969,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Up up up and away","listText":"Up up up and away","text":"Up up up and away","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869930250","repostId":"1165739145","repostType":4,"repost":{"id":"1165739145","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632231054,"share":"https://ttm.financial/m/news/1165739145?lang=&edition=fundamental","pubTime":"2021-09-21 21:30","market":"us","language":"en","title":"U.S. stocks gain at Tuesday's open","url":"https://stock-news.laohu8.com/highlight/detail?id=1165739145","media":"Tiger Newspress","summary":"(Sept 21) U.S. stocks gain at Tuesday's open. Dow Jones, S&P and Nasdaq start higher following yeste","content":"<p>(Sept 21)&nbsp;U.S. stocks gain at Tuesday's open.&nbsp;Dow Jones, S&amp;P and Nasdaq start higher following yesterday's selloff.</p>\n<p>Uber shares jumped 7%&nbsp;after raising its outlook&nbsp;for the third quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/76c76d195eaa24d0309a2ef2686f857c\" tg-width=\"1110\" tg-height=\"570\" width=\"100%\" height=\"auto\"></p>\n<p>Luckin Coffee surged&nbsp;17%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after&nbsp;it&nbsp;Files Annual Report for Fiscal 2020,&nbsp;it's&nbsp;FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.</p>\n<p><img src=\"https://static.tigerbbs.com/a3ab3b5d35e96e056850f7b1739d7a86\" tg-width=\"1111\" tg-height=\"568\" referrerpolicy=\"no-referrer\"></p>\n<p>QuantumScape soars nearly&nbsp;10%&nbsp;after another deal with 'top ten' automaker.</p>\n<p><img src=\"https://static.tigerbbs.com/19b0517a9824a37a70b8f1d10c5f2fd9\" tg-width=\"1111\" tg-height=\"566\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks gain at Tuesday's open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks gain at Tuesday's open\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-21 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 21)&nbsp;U.S. stocks gain at Tuesday's open.&nbsp;Dow Jones, S&amp;P and Nasdaq start higher following yesterday's selloff.</p>\n<p>Uber shares jumped 7%&nbsp;after raising its outlook&nbsp;for the third quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/76c76d195eaa24d0309a2ef2686f857c\" tg-width=\"1110\" tg-height=\"570\" width=\"100%\" height=\"auto\"></p>\n<p>Luckin Coffee surged&nbsp;17%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after&nbsp;it&nbsp;Files Annual Report for Fiscal 2020,&nbsp;it's&nbsp;FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.</p>\n<p><img src=\"https://static.tigerbbs.com/a3ab3b5d35e96e056850f7b1739d7a86\" tg-width=\"1111\" tg-height=\"568\" referrerpolicy=\"no-referrer\"></p>\n<p>QuantumScape soars nearly&nbsp;10%&nbsp;after another deal with 'top ten' automaker.</p>\n<p><img src=\"https://static.tigerbbs.com/19b0517a9824a37a70b8f1d10c5f2fd9\" tg-width=\"1111\" tg-height=\"566\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165739145","content_text":"(Sept 21) U.S. stocks gain at Tuesday's open. Dow Jones, S&P and Nasdaq start higher following yesterday's selloff.\nUber shares jumped 7% after raising its outlook for the third quarter.\n\nLuckin Coffee surged 17% in early trading after it Files Annual Report for Fiscal 2020, it's FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.\n\nQuantumScape soars nearly 10% after another deal with 'top ten' automaker.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159371634,"gmtCreate":1624944505828,"gmtModify":1703848556120,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Nice sharing","listText":"Nice sharing","text":"Nice sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159371634","repostId":"1104807513","repostType":2,"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159379169,"gmtCreate":1624944344451,"gmtModify":1703848553210,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Whoa","listText":"Whoa","text":"Whoa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159379169","repostId":"1113711731","repostType":4,"repost":{"id":"1113711731","pubTimestamp":1624937958,"share":"https://ttm.financial/m/news/1113711731?lang=&edition=fundamental","pubTime":"2021-06-29 11:39","market":"us","language":"en","title":"NIO Stock Is Going Nuts. This Is the Best Explanation.","url":"https://stock-news.laohu8.com/highlight/detail?id=1113711731","media":"Barrons","summary":"Stock in Chinese electric vehicle maker NIO is on fire. While a surge in the volume of options tradi","content":"<p>Stock in Chinese electric vehicle maker&nbsp;NIO&nbsp;is&nbsp;on fire. While a surge in the volume of options trading isn’t a perfect explanation for the rally, it certainlyhelped shares soaron Monday.</p>\n<p>NIO (ticker: NIO) stock gained almost 10% Monday and shares are up 28% over the past month. The&nbsp;S&amp;P 500,for comparison, rose 0.2% Monday and is up 2% over the past month. Call options volume, which rose almost 200% on Monday compared to Friday, is perhaps the biggest reason NIO shares might be more volatile.</p>\n<p>Call options give the holder the right to buy a stock at a fixed price. (Buying a call is a bullish take on the underlying stock.) Brokers will sell and trade options contracts because they want to earn a commission on a trade. But brokers don’t want to be short a call option, which means they’ll have to take a loss if the stock rises.</p>\n<p>One way brokers can hedge options positions is to buy the underlying stock. If a broker sells a call and buys the stock, they can earn the options commission and, if the stock rises, they can deliver the stock purchased to the call holder. In that scenario, the broker doesn’t have to buy shares at a higher price. That process is one way higher-than-average call buying can drive buying in the underlying stock.</p>\n<p>Other factors don’t seem to be at play. Wall Street, for example, can’t be credited with the rally. The average analystprice targetfor NIO stock is up about 1% over the past month and not much has happened to those targets since the companyreported earningsat the end of April. Looking back to that point, the average analyst price target has gone up about $1 to a little more than $59 a share.</p>\n<p>News doesn’t seem to be a credible reason for NIO’s rally, either. The last release on NIO’s website is fromJune 1when the company reported May deliveries. Those numbers relieved investors because the electric vehicle company maintained second-quarter delivery guidance despite a global automotive semiconductor shortage that has roiled the entire industry.</p>\n<p>NIO shares are now up 1% year to date. It’s been a wild ride so far in 2021. Based on recent trading, the ride will continue.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Stock Is Going Nuts. This Is the Best Explanation.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Stock Is Going Nuts. This Is the Best Explanation.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 11:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nio-stock-options-volume-51624921009?siteid=yhoof2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock in Chinese electric vehicle maker NIO is on fire. While a surge in the volume of options trading isn’t a perfect explanation for the rally, it certainlyhelped shares soaron Monday.\nNIO (ticker: ...</p>\n\n<a href=\"https://www.barrons.com/articles/nio-stock-options-volume-51624921009?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://www.barrons.com/articles/nio-stock-options-volume-51624921009?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113711731","content_text":"Stock in Chinese electric vehicle maker NIO is on fire. While a surge in the volume of options trading isn’t a perfect explanation for the rally, it certainlyhelped shares soaron Monday.\nNIO (ticker: NIO) stock gained almost 10% Monday and shares are up 28% over the past month. The S&P 500,for comparison, rose 0.2% Monday and is up 2% over the past month. Call options volume, which rose almost 200% on Monday compared to Friday, is perhaps the biggest reason NIO shares might be more volatile.\nCall options give the holder the right to buy a stock at a fixed price. (Buying a call is a bullish take on the underlying stock.) Brokers will sell and trade options contracts because they want to earn a commission on a trade. But brokers don’t want to be short a call option, which means they’ll have to take a loss if the stock rises.\nOne way brokers can hedge options positions is to buy the underlying stock. If a broker sells a call and buys the stock, they can earn the options commission and, if the stock rises, they can deliver the stock purchased to the call holder. In that scenario, the broker doesn’t have to buy shares at a higher price. That process is one way higher-than-average call buying can drive buying in the underlying stock.\nOther factors don’t seem to be at play. Wall Street, for example, can’t be credited with the rally. The average analystprice targetfor NIO stock is up about 1% over the past month and not much has happened to those targets since the companyreported earningsat the end of April. Looking back to that point, the average analyst price target has gone up about $1 to a little more than $59 a share.\nNews doesn’t seem to be a credible reason for NIO’s rally, either. The last release on NIO’s website is fromJune 1when the company reported May deliveries. Those numbers relieved investors because the electric vehicle company maintained second-quarter delivery guidance despite a global automotive semiconductor shortage that has roiled the entire industry.\nNIO shares are now up 1% year to date. It’s been a wild ride so far in 2021. Based on recent trading, the ride will continue.","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166746541,"gmtCreate":1624026312683,"gmtModify":1703826993644,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166746541","repostId":"1171510497","repostType":4,"repost":{"id":"1171510497","pubTimestamp":1624024592,"share":"https://ttm.financial/m/news/1171510497?lang=&edition=fundamental","pubTime":"2021-06-18 21:56","market":"us","language":"en","title":"Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=1171510497","media":"benzinga","summary":"AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the c","content":"<ul>\n <li><b>AstraZeneca Plc</b>&nbsp;claims victory in a court tussle&nbsp;with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.</li>\n <li>The company had planned 120 million vaccine doses cumulatively by the end of June 2021 and 300 million doses by the end of September.</li>\n <li>AZN intends to deliver more than 70 million by the end of the month.</li>\n <li>A judge ordered delivery of 80.2M doses by the end of September.</li>\n <li>The judgment also acknowledged that the company experienced substantial difficulties in producing the vaccine, which explains the delay.</li>\n <li>Last month, the E.U.’s lawyer had asked the court to force AZN to pay €10 per dose for each day of delay&nbsp;as compensation for breaching the E.U. contract.</li>\n <li><b>Price Action</b>: AZN shares are down 0.75% at $57.91 during the premarket trading session on the last check Friday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCourt Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.\nThe company ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171510497","content_text":"AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.\nThe company had planned 120 million vaccine doses cumulatively by the end of June 2021 and 300 million doses by the end of September.\nAZN intends to deliver more than 70 million by the end of the month.\nA judge ordered delivery of 80.2M doses by the end of September.\nThe judgment also acknowledged that the company experienced substantial difficulties in producing the vaccine, which explains the delay.\nLast month, the E.U.’s lawyer had asked the court to force AZN to pay €10 per dose for each day of delay as compensation for breaching the E.U. contract.\nPrice Action: AZN shares are down 0.75% at $57.91 during the premarket trading session on the last check Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166748876,"gmtCreate":1624026279295,"gmtModify":1703826991542,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"Gr qt","listText":"Gr qt","text":"Gr qt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166748876","repostId":"2144775875","repostType":4,"repost":{"id":"2144775875","pubTimestamp":1624024260,"share":"https://ttm.financial/m/news/2144775875?lang=&edition=fundamental","pubTime":"2021-06-18 21:51","market":"us","language":"en","title":"Next Market Crash: 2 Top Growth Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2144775875","media":"Motley Fool","summary":"Don't wait to jump on this red-hot tech company and unstoppable dividend stock.","content":"<p>The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and trying to time the market to predict the best windows for buying stocks can be a recipe for disaster.</p>\n<p>No matter how worried you may be about a crash, it's always a great time to invest in high-quality stocks that generate wealth-building portfolio returns. To that end, let's take a look at two top stocks that can help your portfolio navigate the next market storm and provide meaningful sources of growth for years to come.</p>\n<h2>1. <a href=\"https://laohu8.com/S/FB\">Facebook</a></h2>\n<p><b>Facebook</b> (NASDAQ:FB) is hardly a new choice for long-term investors, but it's the type of stock you can add more of to your portfolio time and time again. The popular FAANG stock has gained approximately 25% since the beginning of 2021, and is up an eye-popping 41% compared to the same time last year.</p>\n<p>Facebook continues to control a massive share of the social media industry. According to Statista, \"Facebook accounted for nearly 71.8% of all social media site visits in the United States in May 2021.\" The company's ever-increasing market share is also driving exponential balance sheet growth.</p>\n<p>2020 was just another strong year in the books for Facebook, during which its total revenues increased 22% and its net income rose 58%. But Facebook's financial performance in the first quarter of 2021 left these figures in the dust. The company reported that its revenues surged 48% year over year during the three-month period.</p>\n<p>Facebook's net income grew by an even higher percentage -- a whopping 94% from the year-ago stretch. In addition, Facebook reported that its \"daily active users\" (what it calls daily Facebook users) and \"daily active people\" (what it calls daily users of any of Facebook's suite of products) surged by respective rates of 8% and 15% in the month of March alone.</p>\n<p>If you're wondering whether it's too late to buy Facebook on account of its upside potential, the answer is a resounding no. Facebook has plenty of juice left in it for long-term investors. And analysts currently estimate that the company can consistently deliver more than 20% average annual earnings growth for at least the next five years.</p>\n<p>After nearly two decades in business, Facebook continues to expand its market share and reassert its dominance of the social media sphere. This is a premium stock you can hold onto through both market highs and lows, <a href=\"https://laohu8.com/S/AONE\">one</a> that can generate consistent growth and maximize your portfolio returns.</p>\n<h2>2. AbbVie</h2>\n<p>Healthcare stock <b>AbbVie</b> (NYSE:ABBV) is another golden egg to have in your basket before the next market crash rolls around. AbbVie spun off from <b>Abbott Laboratories </b>in 2013, and its former parent company is a veteran member of the elite stock club known as Dividend Aristocrats.</p>\n<p>Stocks that snag the title of Dividend Aristocrats must raise their dividend for 25 consecutive years, and Abbott has done so for nearly 50. As a spinoff of Abbott, AbbVie is also considered a member of the Dividend Aristocrat club. It yields a robust 4.5% for investors at the time of this writing.</p>\n<p>The biggest concern some investors have about AbbVie is the looming loss of U.S. patent protection for its blockbuster drug Humira in 2023. Humira is an immunosuppressive drug used to treat a range of conditions from arthritis to Crohn's disease. It raked in more sales than any other drug in the entire world in 2020 -- amassing total net revenues just shy of $20 billion during the 12-month period.</p>\n<p>There's no doubt that AbbVie's balance sheet will reflect the loss of Humira's patent exclusivity in the U.S. in a few years. We need only look to AbbVie's loss of patent exclusivity in Europe -- which largely took effect in October 2018 -- as an example of this.</p>\n<p>Case in point: International sales of Humira were down 14% in 2020, but still totaled nearly $4 billion. In short, heightened competition in the U.S. will certainly detract from Humira's sales come 2023, but that doesn't mean that sales of the drug can't still inject healthy growth into AbbVie's balance sheet over the long term.</p>\n<p>It's also important to note that AbbVie has a rock-star portfolio of top-selling drugs besides Humira. These include plaque psoriasis drug Skyrizi, cancer drugs Imbruvica and Venclexta, and rheumatoid arthritis drug Rinvoq. Moreover, AbbVie's acquisition of Allergan last year ushered well-known product names like Botox into its portfolio of lucrative products.</p>\n<p>AbbVie's first-quarter 2021 revenues of $13 billion represented a huge 51% increase from the year-ago period. Breaking AbbVie's first-quarter performance down by its top business segments -- immunology, hematologic oncology, aesthetics (which includes Botox Cosmetic), and neuroscience (which includes Botox Therapeutic) -- these four divisions marked respective year-over-year revenue growth of 13%, 8%, 35%, and 100%.</p>\n<p>If you're looking for steady portfolio growth and attractive dividend income to anchor your portfolio in the next market storm, AbbVie offers shareholders the unbeatable combination of both.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Market Crash: 2 Top Growth Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Market Crash: 2 Top Growth Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144775875","content_text":"The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and trying to time the market to predict the best windows for buying stocks can be a recipe for disaster.\nNo matter how worried you may be about a crash, it's always a great time to invest in high-quality stocks that generate wealth-building portfolio returns. To that end, let's take a look at two top stocks that can help your portfolio navigate the next market storm and provide meaningful sources of growth for years to come.\n1. Facebook\nFacebook (NASDAQ:FB) is hardly a new choice for long-term investors, but it's the type of stock you can add more of to your portfolio time and time again. The popular FAANG stock has gained approximately 25% since the beginning of 2021, and is up an eye-popping 41% compared to the same time last year.\nFacebook continues to control a massive share of the social media industry. According to Statista, \"Facebook accounted for nearly 71.8% of all social media site visits in the United States in May 2021.\" The company's ever-increasing market share is also driving exponential balance sheet growth.\n2020 was just another strong year in the books for Facebook, during which its total revenues increased 22% and its net income rose 58%. But Facebook's financial performance in the first quarter of 2021 left these figures in the dust. The company reported that its revenues surged 48% year over year during the three-month period.\nFacebook's net income grew by an even higher percentage -- a whopping 94% from the year-ago stretch. In addition, Facebook reported that its \"daily active users\" (what it calls daily Facebook users) and \"daily active people\" (what it calls daily users of any of Facebook's suite of products) surged by respective rates of 8% and 15% in the month of March alone.\nIf you're wondering whether it's too late to buy Facebook on account of its upside potential, the answer is a resounding no. Facebook has plenty of juice left in it for long-term investors. And analysts currently estimate that the company can consistently deliver more than 20% average annual earnings growth for at least the next five years.\nAfter nearly two decades in business, Facebook continues to expand its market share and reassert its dominance of the social media sphere. This is a premium stock you can hold onto through both market highs and lows, one that can generate consistent growth and maximize your portfolio returns.\n2. AbbVie\nHealthcare stock AbbVie (NYSE:ABBV) is another golden egg to have in your basket before the next market crash rolls around. AbbVie spun off from Abbott Laboratories in 2013, and its former parent company is a veteran member of the elite stock club known as Dividend Aristocrats.\nStocks that snag the title of Dividend Aristocrats must raise their dividend for 25 consecutive years, and Abbott has done so for nearly 50. As a spinoff of Abbott, AbbVie is also considered a member of the Dividend Aristocrat club. It yields a robust 4.5% for investors at the time of this writing.\nThe biggest concern some investors have about AbbVie is the looming loss of U.S. patent protection for its blockbuster drug Humira in 2023. Humira is an immunosuppressive drug used to treat a range of conditions from arthritis to Crohn's disease. It raked in more sales than any other drug in the entire world in 2020 -- amassing total net revenues just shy of $20 billion during the 12-month period.\nThere's no doubt that AbbVie's balance sheet will reflect the loss of Humira's patent exclusivity in the U.S. in a few years. We need only look to AbbVie's loss of patent exclusivity in Europe -- which largely took effect in October 2018 -- as an example of this.\nCase in point: International sales of Humira were down 14% in 2020, but still totaled nearly $4 billion. In short, heightened competition in the U.S. will certainly detract from Humira's sales come 2023, but that doesn't mean that sales of the drug can't still inject healthy growth into AbbVie's balance sheet over the long term.\nIt's also important to note that AbbVie has a rock-star portfolio of top-selling drugs besides Humira. These include plaque psoriasis drug Skyrizi, cancer drugs Imbruvica and Venclexta, and rheumatoid arthritis drug Rinvoq. Moreover, AbbVie's acquisition of Allergan last year ushered well-known product names like Botox into its portfolio of lucrative products.\nAbbVie's first-quarter 2021 revenues of $13 billion represented a huge 51% increase from the year-ago period. Breaking AbbVie's first-quarter performance down by its top business segments -- immunology, hematologic oncology, aesthetics (which includes Botox Cosmetic), and neuroscience (which includes Botox Therapeutic) -- these four divisions marked respective year-over-year revenue growth of 13%, 8%, 35%, and 100%.\nIf you're looking for steady portfolio growth and attractive dividend income to anchor your portfolio in the next market storm, AbbVie offers shareholders the unbeatable combination of both.","news_type":1},"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166740195,"gmtCreate":1624026146017,"gmtModify":1703826986337,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578209189176690","idStr":"3578209189176690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a><a href=\"https://laohu8.com/S/PLTR\"></a>Long term potential","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a><a href=\"https://laohu8.com/S/PLTR\"></a>Long term potential","text":"$Palantir Technologies Inc.(PLTR)$Long term potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/166740195","isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":166740195,"gmtCreate":1624026146017,"gmtModify":1703826986337,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a><a href=\"https://laohu8.com/S/PLTR\"></a>Long term potential","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a><a href=\"https://laohu8.com/S/PLTR\"></a>Long term potential","text":"$Palantir Technologies Inc.(PLTR)$Long term potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/166740195","isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869930250,"gmtCreate":1632233667670,"gmtModify":1676530730969,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Up up up and away","listText":"Up up up and away","text":"Up up up and away","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869930250","repostId":"1165739145","repostType":4,"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159379169,"gmtCreate":1624944344451,"gmtModify":1703848553210,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Whoa","listText":"Whoa","text":"Whoa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159379169","repostId":"1113711731","repostType":4,"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166746541,"gmtCreate":1624026312683,"gmtModify":1703826993644,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166746541","repostId":"1171510497","repostType":4,"repost":{"id":"1171510497","pubTimestamp":1624024592,"share":"https://ttm.financial/m/news/1171510497?lang=&edition=fundamental","pubTime":"2021-06-18 21:56","market":"us","language":"en","title":"Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=1171510497","media":"benzinga","summary":"AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the c","content":"<ul>\n <li><b>AstraZeneca Plc</b>&nbsp;claims victory in a court tussle&nbsp;with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.</li>\n <li>The company had planned 120 million vaccine doses cumulatively by the end of June 2021 and 300 million doses by the end of September.</li>\n <li>AZN intends to deliver more than 70 million by the end of the month.</li>\n <li>A judge ordered delivery of 80.2M doses by the end of September.</li>\n <li>The judgment also acknowledged that the company experienced substantial difficulties in producing the vaccine, which explains the delay.</li>\n <li>Last month, the E.U.’s lawyer had asked the court to force AZN to pay €10 per dose for each day of delay&nbsp;as compensation for breaching the E.U. contract.</li>\n <li><b>Price Action</b>: AZN shares are down 0.75% at $57.91 during the premarket trading session on the last check Friday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCourt Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.\nThe company ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.benzinga.com/general/biotech/21/06/21625016/court-rules-in-favor-of-astrazeneca-over-delay-in-covid-19-shot-deliveries","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171510497","content_text":"AstraZeneca Plc claims victory in a court tussle with the European Union over allegations that the company was not producing shots fast enough, thus missing COVID-19 vaccine deliveries.\nThe company had planned 120 million vaccine doses cumulatively by the end of June 2021 and 300 million doses by the end of September.\nAZN intends to deliver more than 70 million by the end of the month.\nA judge ordered delivery of 80.2M doses by the end of September.\nThe judgment also acknowledged that the company experienced substantial difficulties in producing the vaccine, which explains the delay.\nLast month, the E.U.’s lawyer had asked the court to force AZN to pay €10 per dose for each day of delay as compensation for breaching the E.U. contract.\nPrice Action: AZN shares are down 0.75% at $57.91 during the premarket trading session on the last check Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325739936772264,"gmtCreate":1720550519586,"gmtModify":1720550524097,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Just don't be the bag holder&nbsp;","listText":"Just don't be the bag holder&nbsp;","text":"Just don't be the bag holder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325739936772264","repostId":"2449477578","repostType":4,"repost":{"id":"2449477578","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1720491278,"share":"https://ttm.financial/m/news/2449477578?lang=&edition=fundamental","pubTime":"2024-07-09 10:14","market":"us","language":"en","title":"Nvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2449477578","media":"Dow Jones","summary":"Companies are spending big to develop their own AI chips so they don't have to keep paying Nvidia. Within a few years, AI chips will sell at a small fraction of Nvidia's 'only game in town' price.Artificial intelligence and seven  stocks have been driving the U.S. market's performance for a while. I agree with the market - these companies are magnificent. I'd want my kids to work for any of them.But there's a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia  when its shares were much lower. I'll always look dumb questioning apostasy until I'm not. I'm used to it.Then the conversation  shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microproce","content":"<html><head></head><body><p>Companies are spending big to develop their own AI chips so they don&#39;t have to keep paying Nvidia</p><p>Within a few years, AI chips will sell at a small fraction of Nvidia&#39;s &#39;only game in town&#39; price.</p><p>Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market&#39;s performance for a while. I agree with the market - these companies are magnificent. I&#39;d want my kids to work for any of them.</p><p>But there&#39;s a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a> when its shares were much lower. I&#39;ll always look dumb questioning apostasy until I&#39;m not. I&#39;m used to it.</p><p>I&#39;m fairly certain what I&#39;m about to say will age well, though not in a linear way. Let me tell you a story.</p><p>I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.</p><p>Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.</p><p>I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.</p><p>A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here&#39;s all you need to know: The laws of economics work the same way with microchips.</p><p>Today, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>, Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, <a href=\"https://laohu8.com/S/META\">Meta Platforms</a>, Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia&#39;s skyrocketing profitability is at their expense. Actually, it&#39;s a capital expenditure - only a portion of their spending that shows up in Nvidia&#39;s revenue shows up in Alphabet&#39;s earnings (income statement expenses), for example.</p><p>As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p><p>Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet&#39;s income statement in the form of depreciation, while the full $40,000 shows up in Nvidia&#39;s revenues. That&#39;s why these companies&#39; free cash flow often is much lower than their income.</p><p>These tech giants aren&#39;t pleased to be paying Nvidia for their needs. So, in addition to Intel <a href=\"https://laohu8.com/S/INTC\">$(INTC)$</a> and AMD <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a>, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven&#39;t heard of are working on AI chips.</p><p>Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia&#39;s &#34;only game in town&#34; price. The cure for high prices is high prices. This is what I love about capitalism.</p><p>The argument I hear about Nvidia stock is that it&#39;s not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it&#39;s a high valuation for a $3 trillion company, it&#39;s not &#34;insane.&#34;</p><p>But, and this is a huge but, the &#34;E&#34; in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia's Stock Is Soaring Largely Thanks to Microsoft, Alphabet and Tech's Other AI Giants. That Won't Last\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-07-09 10:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Companies are spending big to develop their own AI chips so they don&#39;t have to keep paying Nvidia</p><p>Within a few years, AI chips will sell at a small fraction of Nvidia&#39;s &#39;only game in town&#39; price.</p><p>Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market&#39;s performance for a while. I agree with the market - these companies are magnificent. I&#39;d want my kids to work for any of them.</p><p>But there&#39;s a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a> when its shares were much lower. I&#39;ll always look dumb questioning apostasy until I&#39;m not. I&#39;m used to it.</p><p>I&#39;m fairly certain what I&#39;m about to say will age well, though not in a linear way. Let me tell you a story.</p><p>I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.</p><p>Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.</p><p>I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.</p><p>A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here&#39;s all you need to know: The laws of economics work the same way with microchips.</p><p>Today, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>, Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, <a href=\"https://laohu8.com/S/META\">Meta Platforms</a>, Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia&#39;s skyrocketing profitability is at their expense. Actually, it&#39;s a capital expenditure - only a portion of their spending that shows up in Nvidia&#39;s revenue shows up in Alphabet&#39;s earnings (income statement expenses), for example.</p><p>As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p><p>Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet&#39;s income statement in the form of depreciation, while the full $40,000 shows up in Nvidia&#39;s revenues. That&#39;s why these companies&#39; free cash flow often is much lower than their income.</p><p>These tech giants aren&#39;t pleased to be paying Nvidia for their needs. So, in addition to Intel <a href=\"https://laohu8.com/S/INTC\">$(INTC)$</a> and AMD <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a>, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven&#39;t heard of are working on AI chips.</p><p>Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia&#39;s &#34;only game in town&#34; price. The cure for high prices is high prices. This is what I love about capitalism.</p><p>The argument I hear about Nvidia stock is that it&#39;s not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it&#39;s a high valuation for a $3 trillion company, it&#39;s not &#34;insane.&#34;</p><p>But, and this is a huge but, the &#34;E&#34; in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia&#39;s sales will falter, and so will its margins and earnings.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU2458330243.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A-H1\" (SGDHDG) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","NVDA":"英伟达","LU0056508442.USD":"贝莱德世界科技基金A2","BK4512":"苹果概念","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","BK4511":"特斯拉概念","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0109392836.USD":"富兰克林科技股A","BK4514":"搜索引擎","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","BK4554":"元宇宙及AR概念","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4515":"5G概念","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","BK4553":"喜马拉雅资本持仓","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","IE00BD6J9T35.USD":"NEUBERGER BERMAN NEXT GENERATION MOBILITY \"A\" (USD) ACC","LU0276348264.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN\"AUP\" (USD) INC","LU0444971666.USD":"天利全球科技基金","BK4567":"ESG概念","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","BK4555":"新能源车","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","BK4566":"资本集团","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0289941410.SGD":"AB FCP I Dynamic Diversified AX SGD","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4559":"巴菲特持仓","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","BK4550":"红杉资本持仓"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2449477578","content_text":"Companies are spending big to develop their own AI chips so they don't have to keep paying NvidiaWithin a few years, AI chips will sell at a small fraction of Nvidia's 'only game in town' price.Artificial intelligence and seven (supposedly magnificent) stocks have been driving the U.S. market's performance for a while. I agree with the market - these companies are magnificent. I'd want my kids to work for any of them.But there's a magnificent difference between a magnificent company and a magnificent stock - the difference lies in magnificent valuation. The price you pay for the shares of a company, even the magnificent ones, matters. Of course, I could have written these same words about Nvidia $(NVDA)$ when its shares were much lower. I'll always look dumb questioning apostasy until I'm not. I'm used to it.I'm fairly certain what I'm about to say will age well, though not in a linear way. Let me tell you a story.I was talking to a friend. He told me a tree had fallen on his almost-new car. His car was totaled, and he got a check from insurance. He still had the memory of buying a car during the pandemic, how difficult it was and how expensive cars were. He said, to his shock, when he went to buy a replacement, he found car dealers fighting for his business. He got a car at a huge discount to the sticker price, because the market is oversupplied with cars. Predictably, high prices a few years ago led to higher supply today, and thus lower prices.Then the conversation (as you would expect) shifted to the stock market and, of course, Nvidia. He asked me what I thought about it.I told him that the market is now flooded with cars, despite them being difficult to get a few years ago. And the same is happening with GPU chips.A few years ago, some people thought high prices would persist in the car market indefinitely. Though I imagine most people thought that at some point it would end in lower prices. Here's all you need to know: The laws of economics work the same way with microchips.Today, Alphabet $(GOOGL)$, Apple $(AAPL)$, Meta Platforms, Tesla $(TSLA)$ and Amazon $(AMZN)$, for example, are buying a very large number of chips from Nvidia, as it is the only game in town. Nvidia's skyrocketing profitability is at their expense. Actually, it's a capital expenditure - only a portion of their spending that shows up in Nvidia's revenue shows up in Alphabet's earnings (income statement expenses), for example.As competing products hit the market, Nvidia's sales will falter, and so will its margins and earnings.Let me explain, using Alphabet as an example: Nvidia is currently selling some of its AI microprocessors for $40,000 a pop. Microprocessors are capital expenditures, thus they are depreciated over five years or so. Per accounting rules, only $8,000 of the $40,000 Alphabet pays to Nvidia shows up in Alphabet's income statement in the form of depreciation, while the full $40,000 shows up in Nvidia's revenues. That's why these companies' free cash flow often is much lower than their income.These tech giants aren't pleased to be paying Nvidia for their needs. So, in addition to Intel $(INTC)$ and AMD $(AMD)$, these companies are spending big to develop their own AI chips. Moreover, dozens of other companies we haven't heard of are working on AI chips.Fast-forward a few years, and AI chips will sell at a small fraction of Nvidia's \"only game in town\" price. The cure for high prices is high prices. This is what I love about capitalism.The argument I hear about Nvidia stock is that it's not insanely expensive, as it is trading at somewhere around 30-40 times future earnings. True. Though it's a high valuation for a $3 trillion company, it's not \"insane.\"But, and this is a huge but, the \"E\" in this P/E calculation is a bit misleading and provides a false sense of security. As competing products hit the market, Nvidia's sales will falter, and so will its margins and earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166748876,"gmtCreate":1624026279295,"gmtModify":1703826991542,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Gr qt","listText":"Gr qt","text":"Gr qt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166748876","repostId":"2144775875","repostType":4,"repost":{"id":"2144775875","pubTimestamp":1624024260,"share":"https://ttm.financial/m/news/2144775875?lang=&edition=fundamental","pubTime":"2021-06-18 21:51","market":"us","language":"en","title":"Next Market Crash: 2 Top Growth Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2144775875","media":"Motley Fool","summary":"Don't wait to jump on this red-hot tech company and unstoppable dividend stock.","content":"<p>The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and trying to time the market to predict the best windows for buying stocks can be a recipe for disaster.</p>\n<p>No matter how worried you may be about a crash, it's always a great time to invest in high-quality stocks that generate wealth-building portfolio returns. To that end, let's take a look at two top stocks that can help your portfolio navigate the next market storm and provide meaningful sources of growth for years to come.</p>\n<h2>1. <a href=\"https://laohu8.com/S/FB\">Facebook</a></h2>\n<p><b>Facebook</b> (NASDAQ:FB) is hardly a new choice for long-term investors, but it's the type of stock you can add more of to your portfolio time and time again. The popular FAANG stock has gained approximately 25% since the beginning of 2021, and is up an eye-popping 41% compared to the same time last year.</p>\n<p>Facebook continues to control a massive share of the social media industry. According to Statista, \"Facebook accounted for nearly 71.8% of all social media site visits in the United States in May 2021.\" The company's ever-increasing market share is also driving exponential balance sheet growth.</p>\n<p>2020 was just another strong year in the books for Facebook, during which its total revenues increased 22% and its net income rose 58%. But Facebook's financial performance in the first quarter of 2021 left these figures in the dust. The company reported that its revenues surged 48% year over year during the three-month period.</p>\n<p>Facebook's net income grew by an even higher percentage -- a whopping 94% from the year-ago stretch. In addition, Facebook reported that its \"daily active users\" (what it calls daily Facebook users) and \"daily active people\" (what it calls daily users of any of Facebook's suite of products) surged by respective rates of 8% and 15% in the month of March alone.</p>\n<p>If you're wondering whether it's too late to buy Facebook on account of its upside potential, the answer is a resounding no. Facebook has plenty of juice left in it for long-term investors. And analysts currently estimate that the company can consistently deliver more than 20% average annual earnings growth for at least the next five years.</p>\n<p>After nearly two decades in business, Facebook continues to expand its market share and reassert its dominance of the social media sphere. This is a premium stock you can hold onto through both market highs and lows, <a href=\"https://laohu8.com/S/AONE\">one</a> that can generate consistent growth and maximize your portfolio returns.</p>\n<h2>2. AbbVie</h2>\n<p>Healthcare stock <b>AbbVie</b> (NYSE:ABBV) is another golden egg to have in your basket before the next market crash rolls around. AbbVie spun off from <b>Abbott Laboratories </b>in 2013, and its former parent company is a veteran member of the elite stock club known as Dividend Aristocrats.</p>\n<p>Stocks that snag the title of Dividend Aristocrats must raise their dividend for 25 consecutive years, and Abbott has done so for nearly 50. As a spinoff of Abbott, AbbVie is also considered a member of the Dividend Aristocrat club. It yields a robust 4.5% for investors at the time of this writing.</p>\n<p>The biggest concern some investors have about AbbVie is the looming loss of U.S. patent protection for its blockbuster drug Humira in 2023. Humira is an immunosuppressive drug used to treat a range of conditions from arthritis to Crohn's disease. It raked in more sales than any other drug in the entire world in 2020 -- amassing total net revenues just shy of $20 billion during the 12-month period.</p>\n<p>There's no doubt that AbbVie's balance sheet will reflect the loss of Humira's patent exclusivity in the U.S. in a few years. We need only look to AbbVie's loss of patent exclusivity in Europe -- which largely took effect in October 2018 -- as an example of this.</p>\n<p>Case in point: International sales of Humira were down 14% in 2020, but still totaled nearly $4 billion. In short, heightened competition in the U.S. will certainly detract from Humira's sales come 2023, but that doesn't mean that sales of the drug can't still inject healthy growth into AbbVie's balance sheet over the long term.</p>\n<p>It's also important to note that AbbVie has a rock-star portfolio of top-selling drugs besides Humira. These include plaque psoriasis drug Skyrizi, cancer drugs Imbruvica and Venclexta, and rheumatoid arthritis drug Rinvoq. Moreover, AbbVie's acquisition of Allergan last year ushered well-known product names like Botox into its portfolio of lucrative products.</p>\n<p>AbbVie's first-quarter 2021 revenues of $13 billion represented a huge 51% increase from the year-ago period. Breaking AbbVie's first-quarter performance down by its top business segments -- immunology, hematologic oncology, aesthetics (which includes Botox Cosmetic), and neuroscience (which includes Botox Therapeutic) -- these four divisions marked respective year-over-year revenue growth of 13%, 8%, 35%, and 100%.</p>\n<p>If you're looking for steady portfolio growth and attractive dividend income to anchor your portfolio in the next market storm, AbbVie offers shareholders the unbeatable combination of both.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Market Crash: 2 Top Growth Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Market Crash: 2 Top Growth Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/06/18/next-market-crash-101-2-top-growth-stocks-to-buy-r/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144775875","content_text":"The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess, and trying to time the market to predict the best windows for buying stocks can be a recipe for disaster.\nNo matter how worried you may be about a crash, it's always a great time to invest in high-quality stocks that generate wealth-building portfolio returns. To that end, let's take a look at two top stocks that can help your portfolio navigate the next market storm and provide meaningful sources of growth for years to come.\n1. Facebook\nFacebook (NASDAQ:FB) is hardly a new choice for long-term investors, but it's the type of stock you can add more of to your portfolio time and time again. The popular FAANG stock has gained approximately 25% since the beginning of 2021, and is up an eye-popping 41% compared to the same time last year.\nFacebook continues to control a massive share of the social media industry. According to Statista, \"Facebook accounted for nearly 71.8% of all social media site visits in the United States in May 2021.\" The company's ever-increasing market share is also driving exponential balance sheet growth.\n2020 was just another strong year in the books for Facebook, during which its total revenues increased 22% and its net income rose 58%. But Facebook's financial performance in the first quarter of 2021 left these figures in the dust. The company reported that its revenues surged 48% year over year during the three-month period.\nFacebook's net income grew by an even higher percentage -- a whopping 94% from the year-ago stretch. In addition, Facebook reported that its \"daily active users\" (what it calls daily Facebook users) and \"daily active people\" (what it calls daily users of any of Facebook's suite of products) surged by respective rates of 8% and 15% in the month of March alone.\nIf you're wondering whether it's too late to buy Facebook on account of its upside potential, the answer is a resounding no. Facebook has plenty of juice left in it for long-term investors. And analysts currently estimate that the company can consistently deliver more than 20% average annual earnings growth for at least the next five years.\nAfter nearly two decades in business, Facebook continues to expand its market share and reassert its dominance of the social media sphere. This is a premium stock you can hold onto through both market highs and lows, one that can generate consistent growth and maximize your portfolio returns.\n2. AbbVie\nHealthcare stock AbbVie (NYSE:ABBV) is another golden egg to have in your basket before the next market crash rolls around. AbbVie spun off from Abbott Laboratories in 2013, and its former parent company is a veteran member of the elite stock club known as Dividend Aristocrats.\nStocks that snag the title of Dividend Aristocrats must raise their dividend for 25 consecutive years, and Abbott has done so for nearly 50. As a spinoff of Abbott, AbbVie is also considered a member of the Dividend Aristocrat club. It yields a robust 4.5% for investors at the time of this writing.\nThe biggest concern some investors have about AbbVie is the looming loss of U.S. patent protection for its blockbuster drug Humira in 2023. Humira is an immunosuppressive drug used to treat a range of conditions from arthritis to Crohn's disease. It raked in more sales than any other drug in the entire world in 2020 -- amassing total net revenues just shy of $20 billion during the 12-month period.\nThere's no doubt that AbbVie's balance sheet will reflect the loss of Humira's patent exclusivity in the U.S. in a few years. We need only look to AbbVie's loss of patent exclusivity in Europe -- which largely took effect in October 2018 -- as an example of this.\nCase in point: International sales of Humira were down 14% in 2020, but still totaled nearly $4 billion. In short, heightened competition in the U.S. will certainly detract from Humira's sales come 2023, but that doesn't mean that sales of the drug can't still inject healthy growth into AbbVie's balance sheet over the long term.\nIt's also important to note that AbbVie has a rock-star portfolio of top-selling drugs besides Humira. These include plaque psoriasis drug Skyrizi, cancer drugs Imbruvica and Venclexta, and rheumatoid arthritis drug Rinvoq. Moreover, AbbVie's acquisition of Allergan last year ushered well-known product names like Botox into its portfolio of lucrative products.\nAbbVie's first-quarter 2021 revenues of $13 billion represented a huge 51% increase from the year-ago period. Breaking AbbVie's first-quarter performance down by its top business segments -- immunology, hematologic oncology, aesthetics (which includes Botox Cosmetic), and neuroscience (which includes Botox Therapeutic) -- these four divisions marked respective year-over-year revenue growth of 13%, 8%, 35%, and 100%.\nIf you're looking for steady portfolio growth and attractive dividend income to anchor your portfolio in the next market storm, AbbVie offers shareholders the unbeatable combination of both.","news_type":1},"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159371634,"gmtCreate":1624944505828,"gmtModify":1703848556120,"author":{"id":"3578209189176690","authorId":"3578209189176690","name":"timtamtom","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578209189176690","authorIdStr":"3578209189176690"},"themes":[],"htmlText":"Nice sharing","listText":"Nice sharing","text":"Nice sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159371634","repostId":"1104807513","repostType":2,"repost":{"id":"1104807513","pubTimestamp":1624447558,"share":"https://ttm.financial/m/news/1104807513?lang=&edition=fundamental","pubTime":"2021-06-23 19:25","market":"us","language":"en","title":"ARKK: Buy On Weakness Before It Leaves Without You","url":"https://stock-news.laohu8.com/highlight/detail?id=1104807513","media":"seekingalpha","summary":"Summary\n\nARK Innovation ETF lost almost 40% from its Feb high to the depths in May as it also experi","content":"<p><b>Summary</b></p>\n<ul>\n <li>ARK Innovation ETF lost almost 40% from its Feb high to the depths in May as it also experienced its worst fund outflows in over a year.</li>\n <li>While fear took over many of ARKK’s investors, long-term ARKK investors know nothing has changed, as secular growth drivers remain well intact.</li>\n <li>Long-term investors should take advantage of its price weakness to add more positions of ARK’s flagship ETF.</li>\n</ul>\n<p><b>Investment Thesis</b></p>\n<p>ARK Innovation ETF(NYSEARCA:ARKK)is a popular ETF among retail investors who wish to gain access to disruptive companies in their respective industries. We present our case on whether ARK has lost its “mojo” as it underperformed the broader index ETFs this year, or whether its highest conviction companies remain at the forefront of benefiting from rapid growth drivers ahead.</p>\n<p>ARKK's Highest Conviction Holdings</p>\n<p><img src=\"https://static.tigerbbs.com/6d9d114e082d89c9545bffa12cf3fe50\" tg-width=\"692\" tg-height=\"396\" referrerpolicy=\"no-referrer\"></p>\n<p>ARKK Top Holdings. Data source: Koyfin</p>\n<p>ARKK lost about 40% during the recent growth stocks rotation that spooked investors in the companies that formed the top ten largest holdings in ARKK, that collectively accounted for more than 50% of the ETF’s holdings. Although the ETF has recovered somewhat from its lows, it remained 26% away from its Feb high. The rotation has also claimed many of its top holdings as they remained some distance below their respective recent highs: Tesla (TSLA): 32%, Teladoc (TDOC): 50%, Roku, Inc (ROKU): 25%, Shopify (SHOP): 2%, Square (SQ): 17%, Zoom (ZM): 37%, Twilio (TWLO): 20%, Spotify (SPOT): 36%, Unity (U): 40% and Coinbase (COIN): 47%.</p>\n<p>ARKK Fund Flows (1Y period). Source: etfdb</p>\n<p>As a result, investors exited the ETF in droves as the fund suffered its worst outflows over the last one year from Mar to May (with a respite in Apr). Our opinion is astute investors took the chance to sell ARKK into strength in Feb as many late buyers to the market couldn’t wait to chase growth stocks to the sky, that also dragged down many fearful investors over these two months.</p>\n<p>We believe no discussion of ARKK is ever complete without focusing on the fundamentals and growth drivers of the ETF’s highest conviction holdings that we summarise below. We believe the secular growth drivers supporting ARKK’s highest conviction holdings have not changed, while their valuations have gotten a lot more attractive.</p>\n<p><b>Tesla: ARK Estimates There is a 50% Chance that TSLA Would Achieve Fully Autonomous Driving by 2025</b></p>\n<p><img src=\"https://static.tigerbbs.com/7915c3196af23e54013216a209076529\" tg-width=\"600\" tg-height=\"371\" referrerpolicy=\"no-referrer\"></p>\n<p>Estimated U.S. market share of automakers. Data source: GoodCarBadCar.net</p>\n<p>Estimated plug-in EV sales worldwide. Data source: CleanTechnica; EV-Volumes.com</p>\n<p>Investors need no further introduction to TSLA. What’s more important is that while TSLA represented only 2% of the automakers' market share in the U.S., it’s the worldwide leader in EV sales by a fairly large margin. It goes to show the tremendous amount of opportunity for TSLA to capture in the years ahead as the industry’s EV leader.</p>\n<p><img src=\"https://static.tigerbbs.com/3a1d3ce3dc2d4d9a2265995ad24eb957\" tg-width=\"600\" tg-height=\"371\" referrerpolicy=\"no-referrer\"></p>\n<p>L4/5 autonomous vehicles market share. Data source: Deloitte</p>\n<p>TSLA investors know that the company’s lead would hardly be confined to just EV, as that’s just the tip of the iceberg. What makes TSLA such a high conviction pick for ARK is how its lead in EV and full self-driving [FSD] development would open up huge potential opportunities for the company. ARK emphasized:</p>\n<blockquote>\n In our last valuation model, ARK assumed that Tesla had a 30% chance of delivering fully autonomous driving in the five years ended 2024. Now,ARK estimates that the probability is 50% by 2025. Since our last forecast, neural networks have solved many complex problems previously considered unsolvable, increasing the probability that robotaxis are viable. ARK estimates that Tesla’s vehicle fleet gives it access to 30-40 million miles of data per day, up from 20 million per day last year. If successful, Tesla could scale its robotaxi service rapidly, allocating the additional cash in turn to manufacturing capacity serving its autonomous network.\n</blockquote>\n<p>The chart above also gives investors an idea on how Tesla’s lead may transform the entire auto industry by 2035 where in the “disruptive” scenario 59% and 66% of vehicles would be Level 4 or 5 autonomous vehicles, giving the market leader an enormous share of the market, just in auto sales alone. We have not even accounted for revenue streams that could come from other areas such as robotaxi service as highlighted by ARK.</p>\n<p>Of course, not everyone agrees with Tesla’s approach, especially Waymo (unsurprisingly), as well asGuidehouse Insightswho ranked Tesla last again and Waymo first in its latest guide on autonomous driving. Guidehouse said:</p>\n<blockquote>\n “Tesla needs a thorough rethink of its approach to developing its automated driving system [ADS]. It has overpromised with its marketing for nearly 5 years and severely undelivered. Until Tesla is more honest it is unlikely to improve in the rankings of this leaderboard.\"\n</blockquote>\n<p>In addition, Waymo who had long doubted Tesla’s approach to FSD also weighed in again early this year as CEO John Krafcik emphasized:</p>\n<blockquote>\n For us,Tesla is not a competitor at all. We manufacture a completely autonomous driving system. Tesla is an automaker that is developing a really good driver assistance system. It is a misconception that you can just keep developing a driver assistance system until one day you can magically leap to a fully autonomous driving system. In terms of robustness and accuracy, for example, our sensors are orders of magnitude better than what we see on the road from other manufacturers.\n</blockquote>\n<p>For investors, the jury is definitely still out on whether Tesla would be able to succeed, although ARK has long rested its case on TSLA as its highest conviction holding. Investors are encouraged to visitARK’s assumptionswhich detail their assumptions on their bullish stance.</p>\n<p><b>TDOC: Telemedicine Market is Expected to Grow at More Than 20% CAGR over the Next 10 Years</b></p>\n<p>Projected Global Telemedicine market. Data Source: thebusinessresearchcompany.com (TBRC)</p>\n<p>From the chart above we could clearly see that TDOC operates within arapidly growing telemedicine market, that is expected to grow from just $49.9B in 2019 to $459.8B by 2030 in 11 years, which would represent an incredible 25.9% CAGR.</p>\n<p>Telemedicine’s growth had started well before COVID-19 pandemic hit that was then accelerated by the pandemic. However, investors who do not understand TDOC’s growth drivers often lamented that the company’s growth and raison d'être would fizzle out once vaccinations and economies’ reopenings took over. We believe these investors were truly mistaken as TDOC is still expected to generate YoY revenue growth rates in excess of 25% moving forward, that for the emerging leader in telemedicine may even have been on the conservative side as it’s “merely” largely in line with the market’s expected CAGR. Therefore, TDOC’s growth prospects look extremely exciting.</p>\n<p><b>Invest in ARKK or Invest in its Highest Conviction Companies?</b></p>\n<p><img src=\"https://static.tigerbbs.com/3e60603b189daf2329303be82b4b0f98\" tg-width=\"1280\" tg-height=\"694\" referrerpolicy=\"no-referrer\"></p>\n<p>TSLA and TDOC EV / Fwd EBIT. Data source: S&amp;P Capital IQ</p>\n<p>TSLA and TDOC EV / Fwd (EBITDA - CapEx). Data source: S&amp;P Capital IQ</p>\n<p>Growth investors often find themselves undecided on whether to invest in the underlying stocks directly or invest through ARKK. While we don’t think there is a simple answer to this, investors should consider the key benefits of investing in ARKK as compared to investing directly in the underlying stocks.</p>\n<p>While companies such as TSLA and TDOC have massive potential as we could see from both the charts above where their valuations are expected to drop significantly as they continued to scale up and achieve their growth targets (assuming EV remains the same though it’s unrealistic if the companies continue to execute their growth strategies well). However, the fact of the matter remains that their valuations are not cheap whether basing off EBIT or FCF (using EBITDA - CapEx as a proxy) as shown clearly above.</p>\n<p>Therefore, by investing in ARKK you put your money in a widely diversified ETF that’s focused on disruptive companies that are expected to be the leader in the future, although some may not end up to be. Therefore, by investing in ARKK, investors could simply dedicate a disciplined proportion of their portfolio that they are willing to allocate to such disruptive stocks, without the need to fill up their portfolio with lots of them, and taking more risks than what may be appropriate. In addition, as such companies are usually emerging leaders in their respective fields, investors would need to do a lot of groundwork to keep pace with their investments in order to continue evaluating the quality of their thesis moving forward. However, ARK does all the heavy lifting for investors as ARK would actively manage those holdings and would reduce or add exposures to its stocks whenever necessary.</p>\n<p>Therefore, we gladly hold ARKK along with some of the underlying stocks within the ETF in order to benefit from a wide range of disruptive companies that we do not intend to hold as our underlying holdings but wish to gain an exposure to, while holding on to some of ARK's highest conviction picks as our core holdings.</p>\n<p><b>Price Action and Technical Analysis</b></p>\n<p><img src=\"https://static.tigerbbs.com/746f2145c66a240d1b7f32f44ab29c61\" tg-width=\"1280\" tg-height=\"842\" referrerpolicy=\"no-referrer\"></p>\n<p>ARKK has a strong uptrend bias that has been supported along the 20W moving average until it was lost during the rotation we saw between Feb and May. However, it seems like most of the inventory has already been unloaded by the weak holders as $105 looks like a strong support level that has held up well, that also coincided with the 50W moving average. We think that long term investors should not find the current price expensive even though ARKK has recovered somewhat from its May lows. The long term growth drivers remain highly attractive for its underlying stocks and investors should take advantage of the price weakness to initiate or add to ARK’s flagship ETF.</p>\n<p><b>Wrapping It All Up</b></p>\n<p>ARKK represents a convenient way for investors to gain exposure to companies that are expected to grow rapidly and establish themselves as the undisputed leaders in their respective industries.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARKK: Buy On Weakness Before It Leaves Without You</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARKK: Buy On Weakness Before It Leaves Without You\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 19:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435995-arkk-buy-on-weakness-before-it-leaves-without-you><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nARK Innovation ETF lost almost 40% from its Feb high to the depths in May as it also experienced its worst fund outflows in over a year.\nWhile fear took over many of ARKK’s investors, long-...</p>\n\n<a href=\"https://seekingalpha.com/article/4435995-arkk-buy-on-weakness-before-it-leaves-without-you\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF"},"source_url":"https://seekingalpha.com/article/4435995-arkk-buy-on-weakness-before-it-leaves-without-you","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1104807513","content_text":"Summary\n\nARK Innovation ETF lost almost 40% from its Feb high to the depths in May as it also experienced its worst fund outflows in over a year.\nWhile fear took over many of ARKK’s investors, long-term ARKK investors know nothing has changed, as secular growth drivers remain well intact.\nLong-term investors should take advantage of its price weakness to add more positions of ARK’s flagship ETF.\n\nInvestment Thesis\nARK Innovation ETF(NYSEARCA:ARKK)is a popular ETF among retail investors who wish to gain access to disruptive companies in their respective industries. We present our case on whether ARK has lost its “mojo” as it underperformed the broader index ETFs this year, or whether its highest conviction companies remain at the forefront of benefiting from rapid growth drivers ahead.\nARKK's Highest Conviction Holdings\n\nARKK Top Holdings. Data source: Koyfin\nARKK lost about 40% during the recent growth stocks rotation that spooked investors in the companies that formed the top ten largest holdings in ARKK, that collectively accounted for more than 50% of the ETF’s holdings. Although the ETF has recovered somewhat from its lows, it remained 26% away from its Feb high. The rotation has also claimed many of its top holdings as they remained some distance below their respective recent highs: Tesla (TSLA): 32%, Teladoc (TDOC): 50%, Roku, Inc (ROKU): 25%, Shopify (SHOP): 2%, Square (SQ): 17%, Zoom (ZM): 37%, Twilio (TWLO): 20%, Spotify (SPOT): 36%, Unity (U): 40% and Coinbase (COIN): 47%.\nARKK Fund Flows (1Y period). Source: etfdb\nAs a result, investors exited the ETF in droves as the fund suffered its worst outflows over the last one year from Mar to May (with a respite in Apr). Our opinion is astute investors took the chance to sell ARKK into strength in Feb as many late buyers to the market couldn’t wait to chase growth stocks to the sky, that also dragged down many fearful investors over these two months.\nWe believe no discussion of ARKK is ever complete without focusing on the fundamentals and growth drivers of the ETF’s highest conviction holdings that we summarise below. We believe the secular growth drivers supporting ARKK’s highest conviction holdings have not changed, while their valuations have gotten a lot more attractive.\nTesla: ARK Estimates There is a 50% Chance that TSLA Would Achieve Fully Autonomous Driving by 2025\n\nEstimated U.S. market share of automakers. Data source: GoodCarBadCar.net\nEstimated plug-in EV sales worldwide. Data source: CleanTechnica; EV-Volumes.com\nInvestors need no further introduction to TSLA. What’s more important is that while TSLA represented only 2% of the automakers' market share in the U.S., it’s the worldwide leader in EV sales by a fairly large margin. It goes to show the tremendous amount of opportunity for TSLA to capture in the years ahead as the industry’s EV leader.\n\nL4/5 autonomous vehicles market share. Data source: Deloitte\nTSLA investors know that the company’s lead would hardly be confined to just EV, as that’s just the tip of the iceberg. What makes TSLA such a high conviction pick for ARK is how its lead in EV and full self-driving [FSD] development would open up huge potential opportunities for the company. ARK emphasized:\n\n In our last valuation model, ARK assumed that Tesla had a 30% chance of delivering fully autonomous driving in the five years ended 2024. Now,ARK estimates that the probability is 50% by 2025. Since our last forecast, neural networks have solved many complex problems previously considered unsolvable, increasing the probability that robotaxis are viable. ARK estimates that Tesla’s vehicle fleet gives it access to 30-40 million miles of data per day, up from 20 million per day last year. If successful, Tesla could scale its robotaxi service rapidly, allocating the additional cash in turn to manufacturing capacity serving its autonomous network.\n\nThe chart above also gives investors an idea on how Tesla’s lead may transform the entire auto industry by 2035 where in the “disruptive” scenario 59% and 66% of vehicles would be Level 4 or 5 autonomous vehicles, giving the market leader an enormous share of the market, just in auto sales alone. We have not even accounted for revenue streams that could come from other areas such as robotaxi service as highlighted by ARK.\nOf course, not everyone agrees with Tesla’s approach, especially Waymo (unsurprisingly), as well asGuidehouse Insightswho ranked Tesla last again and Waymo first in its latest guide on autonomous driving. Guidehouse said:\n\n “Tesla needs a thorough rethink of its approach to developing its automated driving system [ADS]. It has overpromised with its marketing for nearly 5 years and severely undelivered. Until Tesla is more honest it is unlikely to improve in the rankings of this leaderboard.\"\n\nIn addition, Waymo who had long doubted Tesla’s approach to FSD also weighed in again early this year as CEO John Krafcik emphasized:\n\n For us,Tesla is not a competitor at all. We manufacture a completely autonomous driving system. Tesla is an automaker that is developing a really good driver assistance system. It is a misconception that you can just keep developing a driver assistance system until one day you can magically leap to a fully autonomous driving system. In terms of robustness and accuracy, for example, our sensors are orders of magnitude better than what we see on the road from other manufacturers.\n\nFor investors, the jury is definitely still out on whether Tesla would be able to succeed, although ARK has long rested its case on TSLA as its highest conviction holding. Investors are encouraged to visitARK’s assumptionswhich detail their assumptions on their bullish stance.\nTDOC: Telemedicine Market is Expected to Grow at More Than 20% CAGR over the Next 10 Years\nProjected Global Telemedicine market. Data Source: thebusinessresearchcompany.com (TBRC)\nFrom the chart above we could clearly see that TDOC operates within arapidly growing telemedicine market, that is expected to grow from just $49.9B in 2019 to $459.8B by 2030 in 11 years, which would represent an incredible 25.9% CAGR.\nTelemedicine’s growth had started well before COVID-19 pandemic hit that was then accelerated by the pandemic. However, investors who do not understand TDOC’s growth drivers often lamented that the company’s growth and raison d'être would fizzle out once vaccinations and economies’ reopenings took over. We believe these investors were truly mistaken as TDOC is still expected to generate YoY revenue growth rates in excess of 25% moving forward, that for the emerging leader in telemedicine may even have been on the conservative side as it’s “merely” largely in line with the market’s expected CAGR. Therefore, TDOC’s growth prospects look extremely exciting.\nInvest in ARKK or Invest in its Highest Conviction Companies?\n\nTSLA and TDOC EV / Fwd EBIT. Data source: S&P Capital IQ\nTSLA and TDOC EV / Fwd (EBITDA - CapEx). Data source: S&P Capital IQ\nGrowth investors often find themselves undecided on whether to invest in the underlying stocks directly or invest through ARKK. While we don’t think there is a simple answer to this, investors should consider the key benefits of investing in ARKK as compared to investing directly in the underlying stocks.\nWhile companies such as TSLA and TDOC have massive potential as we could see from both the charts above where their valuations are expected to drop significantly as they continued to scale up and achieve their growth targets (assuming EV remains the same though it’s unrealistic if the companies continue to execute their growth strategies well). However, the fact of the matter remains that their valuations are not cheap whether basing off EBIT or FCF (using EBITDA - CapEx as a proxy) as shown clearly above.\nTherefore, by investing in ARKK you put your money in a widely diversified ETF that’s focused on disruptive companies that are expected to be the leader in the future, although some may not end up to be. Therefore, by investing in ARKK, investors could simply dedicate a disciplined proportion of their portfolio that they are willing to allocate to such disruptive stocks, without the need to fill up their portfolio with lots of them, and taking more risks than what may be appropriate. In addition, as such companies are usually emerging leaders in their respective fields, investors would need to do a lot of groundwork to keep pace with their investments in order to continue evaluating the quality of their thesis moving forward. However, ARK does all the heavy lifting for investors as ARK would actively manage those holdings and would reduce or add exposures to its stocks whenever necessary.\nTherefore, we gladly hold ARKK along with some of the underlying stocks within the ETF in order to benefit from a wide range of disruptive companies that we do not intend to hold as our underlying holdings but wish to gain an exposure to, while holding on to some of ARK's highest conviction picks as our core holdings.\nPrice Action and Technical Analysis\n\nARKK has a strong uptrend bias that has been supported along the 20W moving average until it was lost during the rotation we saw between Feb and May. However, it seems like most of the inventory has already been unloaded by the weak holders as $105 looks like a strong support level that has held up well, that also coincided with the 50W moving average. We think that long term investors should not find the current price expensive even though ARKK has recovered somewhat from its May lows. The long term growth drivers remain highly attractive for its underlying stocks and investors should take advantage of the price weakness to initiate or add to ARK’s flagship ETF.\nWrapping It All Up\nARKK represents a convenient way for investors to gain exposure to companies that are expected to grow rapidly and establish themselves as the undisputed leaders in their respective industries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}